China Shineway Pharmaceutical (02877) said its profit attributable to owners for the six months ended 30 June 2015 dropped 4.8% year-on-year to Rmb385 million, which was mainly attributable to the price adjustment of products and increase in expenses.
Basic earnings per share were Rmb47 cents.
The turnover was Rmb1,109 million, an increase of 0.9% from a year earlier. Gross profit margin was 65.8% as compared to 65.9% of the corresponding period of last year.
The proposed interim dividend is Rmb11 cents (2014: Rmb11 cents) per share, payable on 30 October 2015.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
